Naproxen etemesil

DB12398InvestigationalSmall molecule

Naproxen etemesil has been used in trials studying the treatment of Osteoarthritis.

Chemical structure of Naproxen etemesil
Mechanism
Curator reviewed
Formula / weight
C17H20O5S · 336.4 g/mol (avg)
Code names
LT-NS001 · MX-1094

Resolves to

Compound
UNII214269U36RCAS385800-16-8ChEMBLCHEMBL2105683PubChem25170420
Structure
InChIKeyJGBUBSOKFSVXKS-LBPRGKRZSA-NSMILESCOC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(=O)OCCS(C)(=O)=O

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Naproxen etemesil, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In